1 Peripheral Intervention Drug-Eluting Devices Market Overview
1.1 Peripheral Intervention Drug-Eluting Devices Product Scope
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2020-2026)
1.2.2 Plain Old Balloon Angioplasty (POBA)
1.2.3 Percutaneous Transluminal Angioplasty (PTA)
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Comparison by Application (2020-2026)
1.3.2 Drug-Eluting Balloons
1.3.3 Drug-Eluting Stents
1.4 Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts (2015-2026)
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2015-2026)
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2015-2026)
1.4.3 Global Peripheral Intervention Drug-Eluting Devices Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Peripheral Intervention Drug-Eluting Devices Industry Impact
1.5.1 How the Covid-19 is Affecting the Peripheral Intervention Drug-Eluting Devices Industry
1.5.1.1 Peripheral Intervention Drug-Eluting Devices Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
2 Peripheral Intervention Drug-Eluting Devices Estimate and Forecast by Region
2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2015-2020)
2.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2015-2020)
2.3 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.2 Europe Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.3 China Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.4 Japan Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
2.4.6 India Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2015-2026)
3 Global Peripheral Intervention Drug-Eluting Devices Competition Landscape by Players
3.1 Global Top Peripheral Intervention Drug-Eluting Devices Players by Sales (2015-2020)
3.2 Global Top Peripheral Intervention Drug-Eluting Devices Players by Revenue (2015-2020)
3.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2019)
3.4 Global Peripheral Intervention Drug-Eluting Devices Average Price by Company (2015-2020)
3.5 Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)
4 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Type (2015-2020)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2015-2020)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2014-2020)
4.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)
5 Global Peripheral Intervention Drug-Eluting Devices Market Size by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Application (2015-2020)
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2015-2020)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2015-2020)
5.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2021-2026)
3 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
3.2 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
3.3 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
3.4 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
4 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
4.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
4.3 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
4.4 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
5 China Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
5.2 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
5.3 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
5.4 China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
6 Japan Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
6.2 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
6.3 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
6.4 Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
7 Southeast Asia Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
7.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
8 India Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
8.2 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2015-2020)
8.3 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2015-2020)
8.4 India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Peripheral Intervention Drug-Eluting Devices Business
12.1 Medtronic plc
12.1.1 Medtronic plc Peripheral Intervention Drug-Eluting Devices Corporation Information
12.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered
12.1.5 Medtronic plc Recent Development
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.2.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.2.5 Boston Scientific Corporation Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Corporation Information
12.3.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Products Offered
12.3.5 Abbott Laboratories Recent Development
12.4 Cardinal Health
12.4.1 Cardinal Health Peripheral Intervention Drug-Eluting Devices Corporation Information
12.4.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Products Offered
12.4.5 Cardinal Health Recent Development
12.5 B. Braun Melsungen AG
12.5.1 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Corporation Information
12.5.2 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Products Offered
12.5.5 B. Braun Melsungen AG Recent Development
12.6 Biosensors International Group Ltd.
12.6.1 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Corporation Information
12.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Products Offered
12.6.5 Biosensors International Group Ltd. Recent Development
12.7 C.R. Bard, Inc.
12.7.1 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Corporation Information
12.7.2 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Products Offered
12.7.5 C.R. Bard, Inc. Recent Development
12.8 Abbott
12.8.1 Abbott Peripheral Intervention Drug-Eluting Devices Corporation Information
12.8.2 Abbott Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Products Offered
12.8.5 Abbott Recent Development
12.9 The Lubrizol Corporation
12.9.1 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.9.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.9.5 The Lubrizol Corporation Recent Development
12.10 Terumo Corporation
12.10.1 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Corporation Information
12.10.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Business Overview and Total Revenue
12.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.10.5 Terumo Corporation Recent Development
13 Peripheral Intervention Drug-Eluting Devices Manufacturing Cost Analysis
13.1 Peripheral Intervention Drug-Eluting Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
13.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Peripheral Intervention Drug-Eluting Devices Distributors List
14.3 Peripheral Intervention Drug-Eluting Devices Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
【免責事項】
https://www.globalresearch.jp/disclaimer